— Know what they know.
Not Investment Advice
Also trades as: PEAK (NYSE) · $vol 127M

DOC NYSE

Healthpeak Properties, Inc.
1W: -4.1% 1M: -6.9% 3M: -10.0% YTD: +21.7% 1Y: +3.3% 3Y: +24.8% 5Y: -25.9%
$19.49
+0.05 (+0.26%)
 
Weekly Expected Move ±2.3%
$19 $19 $19 $20 $20
NYSE · Real Estate · REIT - Healthcare Facilities · Tech Score Sell · Power 36 · $13.4B mcap · 687M float · 0.956% daily turnover · Short 52% of daily vol

Supply Chain Overview

14 relationships
12
As Filer
counterparties named
2
As Counterparty
mentioned by others
2
Rel. Types
2021-12-15
Earliest Filing
2025-04-16
Latest Filing
partner: 10 target: 2

Counterparties (Filed by DOC)

12 relationships

Companies named in DOC's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
U.S. Bank Trust Company, National Association — partner Trustee for the Senior Indenture and DOC Notes 2024-03-01 View
The Bank of New York Mellon Trust Company, N.A. — partner Trustee for Healthpeak OP's and Healthpeak's indentures 2024-03-01 View
Physicians Realty Trust PRT target Target company in a merger agreement with Healthpeak Properties, Inc. 2023-10-30 View
Physicians Realty L.P. — target Limited partnership partner in the merger agreement with Healthpeak Properties, Inc. 2023-10-30 View
Barclays Capital Inc. BCLYF partner Sales Agent, Forward Seller, and Forward Purchaser in the at-the-market equity offering 2023-02-17 View
BTIG, LLC — partner Sales Agent, Forward Seller, and Forward Purchaser in the at-the-market equity offering 2023-02-17 View
Goldman Sachs & Co. LLC GSCE partner Sales Agent, Forward Seller, and Forward Purchaser in the at-the-market equity offering 2023-02-17 View
Jefferies LLC JEF partner Sales Agent, Forward Seller, and Forward Purchaser in the at-the-market equity offering 2023-02-17 View
Morgan Stanley & Co. LLC MS-PL partner Sales Agent, Forward Seller, and Forward Purchaser in the at-the-market equity offering 2023-02-17 View
RBC Capital Markets, LLC — partner Sales Agent, Forward Seller, and Forward Purchaser in the at-the-market equity offering 2023-02-17 View
Robert W. Baird & Co. Incorporated — partner Sales Agent, Forward Seller, and Forward Purchaser in the at-the-market equity offering 2023-02-17 View
Scotia Capital (USA) Inc. — partner Sales Agent, Forward Seller, and Forward Purchaser in the at-the-market equity offering 2023-02-17 View

Mentioned As Counterparty

2 mentions

Other companies that named DOC in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
FORR FORRESTER RESEARCH, INC. partner Parent company of LS 200 CDP, LLC, listed as contact for notices. 2025-04-16 View
ALLO Allogene Therapeutics, Inc. customer Landlord for HQ Lease extension 2021-12-15 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-04 Earnings Release; Regulation FD; Exhibits View
2026-05-05 Earnings Release; Regulation FD; Exhibits View
2026-05-04 Shareholder Vote View
2026-03-23 Material Agreement; Financial Obligation; Exhibits Agreement View
2026-02-27 Regulation FD Disclosure View
2026-02-02 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2025-10-23 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2025-08-14 Other Events; Financial Statements and Exhibits View
2025-08-06 Other Events; Financial Statements and Exhibits View
2025-08-05 Other Events; Financial Statements and Exhibits View
2025-07-24 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2025-05-12 Regulation FD Disclosure View
2025-04-28 Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit View
2025-04-24 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
2025-04-24 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2025-04-07 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-02-26 Regulation FD Disclosure View
2025-02-14 Other Events; Financial Statements and Exhibits View
2025-02-06 Other Events; Financial Statements and Exhibits View
2025-02-03 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms